Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 11/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.35 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7489183 | 1.00 | SMN1; SMN2 (0.44) | SMN1; SMN2CASP1CYP3A4SLC22A6TDP1 | |
| Fumaric Acid SCHEMBL16653510 | 0.93 | SMN1; SMN2 (0.39) | SMN1; SMN2CASP1CYP3A4SLC22A6TDP1 | |
| SCHEMBL167301 | 0.83 | TDP1 (0.43) | SMN1; SMN2CASP1CYP3A4TDP1TSHR | |
| SCHEMBL8003148 | 0.82 | SMN1; SMN2 (0.40) | SMN1; SMN2CASP1CYP3A4SLC22A6TDP1 | |
| SCHEMBL7431878 | 0.82 | MAPT (0.42) | CASP1CYP3A4TDP1TSHRMAPT | |
| SCHEMBL7431887 | 0.82 | MAPT (0.42) | CASP1CYP3A4TDP1TSHRMAPT | |
| Ethylene SCHEMBL459401 | 0.81 | TSHR (0.37) | SMN1; SMN2CASP1CYP3A4TSHRMAPT | |
| SCHEMBL7773895 | 0.80 | TDP1 (0.38) | SMN1; SMN2CYP3A4TDP1TSHRMAPT | |
| SCHEMBL18280854 | 0.80 | TET2 (0.48) | SMN1; SMN2CYP3A4TDP1TSHRMAPT | |
| SCHEMBL18280853 | 0.80 | TET2 (0.48) | SMN1; SMN2CYP3A4TDP1TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 963 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240074956-A1 | COSMETIC COMPOSITIONS, KITS THEREOF, AND METHODS FOR MAKING AND USING THE SAME | L'OREAL (FR) | 2024-03-07 | — | — | US | claimed |
| US-11884881-B2 | Delayed gelation of polymers | CONOCOPHILLIPS COMPANY (US) | 2024-01-30 | — | — | US | claimed |
| US-11819560-B2 | Cosmetic compositions, kits thereof, and methods for making and using the same | L'OREAL (FR) | 2023-11-21 | — | — | US | claimed |
| WO-2023164280-A1 | COMPOSITIONS AND METHODS FOR CURLY HAIR | RUGHANI RONAK (US) | 2023-08-31 | — | — | WO | claimed |
| CN-116635001-A | Composition for caring for and/or making up keratin materials | 莱雅公司 | 2023-08-22 | — | — | CN | claimed |
| EP-4203904-A1 | COSMETIC COMPOSITIONS, KITS THEREOF, AND METHODS FOR MAKING AND USING THE SAME | L'OREAL (FR) | 2023-07-05 | — | — | EP | claimed |
| US-20220298409-A1 | DELAYED GELATION OF POLYMERS | UNIVERSITY OF KANSAS (US) | 2022-09-22 | — | — | US | claimed |
| US-11384279-B2 | Delayed gelation of polymers | CONOCOPHILLIPS COMPANY (US) | 2022-07-12 | — | — | US | claimed |
| WO-2022133733-A1 | COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2022-06-30 | — | — | WO | claimed |
| WO-2022000051-A1 | COSMETIC COMPOSITIONS CAPABLE OF FORMING AN EMULSION | L'OREAL (FR) | 2022-01-06 | — | — | WO | claimed |
| EP-1420767-A4 | COMPOSITIONS CONTAINING ITRACONAZOLE AND THEIR PREPARATION METHODS | WON JIN BIOPHARMA CO LTD (KR) | 2004-11-24 | — | — | EP | claimed |
| EP-1420767-A1 | COMPOSITIONS CONTAINING ITRACONAZOLE AND THEIR PREPARATION METHODS | Won Jin Biopharma Co. Ltd. (KR) | 2004-05-26 | — | — | EP | claimed |
| EP-1127898-B1 | Process for production of copolymer composition and water-repellent, oil-repellent agent | NICCA CHEMICAL CO (JP) | 2004-05-19 | — | — | EP | claimed |
| EP-1409023-A1 | COMPOSITIONS AND PREPARATION METHODS FOR BIOAVAILABLE ORAL ACEACECLOFENAC DOSAGE FORMS | Pharm Tech Research, Inc. (KR) | 2004-04-21 | — | — | EP | claimed |
| WO-2003017986-A1 | COMPOSITIONS CONTAINING ITRACONAZOLE AND THEIR PREPARATION METHODS | WON JIN BIOPHARMA CO., LTD. (KR) | 2003-03-06 | — | — | WO | claimed |
| WO-2003004060-A1 | COMPOSITIONS AND PREPARATION METHODS FOR BIOAVAILABLE ORAL ACEACECLOFENAC DOSAGE FORMS | PHARM TECH RESEARCH, INC. (KR) | 2003-01-16 | — | — | WO | claimed |
| EP-1127898-A1 | Process for production of copolymer composition and water-repellent, oil-repellent agent | Nicca Chemical Co., Ltd. (JP) | 2001-08-29 | — | — | EP | claimed |
| WO-2000000179-A1 | SOLID DISPERSED PREPARATION OF POORLY WATER-SOLUBLE DRUG CONTAINING OIL, FATTY ACID OR MIXTURES THEREOF | WON JIN BIOPHARMA CO., LTD. (KR) | 2000-01-06 | — | — | WO | claimed |
| EP-0005496-B1 | FLAME RETARDANT POLYPROPENE FIBRES AND PROCESS FOR MANUFACTURING THEM | CHEMIE LINZ AKTIENGESELLSCHAFT (AT) | 1981-07-15 | — | — | EP | claimed |
| US-4220744-A | Mass polymerization process | VIANOVA KUNSTHARZ, A.G. (AT) | 1980-09-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240074956-A1 | COSMETIC COMPOSITIONS, KITS THEREOF, AND METHODS FOR MAKING AND USING THE SAME | CUTA, LIPC, MGLL | SMN1; SMN2 4208/4885CASP1 2451/4885CYP3A4 4311/4885 |
| US-11819560-B2 | Cosmetic compositions, kits thereof, and methods for making and using the same | CUTA, LIPC, MGLL | SMN1; SMN2 4208/4885CASP1 2451/4885CYP3A4 4311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.